China’s FDA: New Name, New Ministerial Level

By Dan Stanton contact

- Last updated on GMT

Related tags: Food and drug administration

SFDA renamed CFDA
SFDA renamed CFDA
Following its re-elevation to a ministerial level, the Chinese drug regulatory body has rebranded itself the China Food and Drug Administration (CFDA).

The change from ‘State’ to ‘China’ in the name of the body is, according to the China Daily​, part of “the country's renewed efforts to reduce bureaucracy and improve efficiency via a cabinet restructuring.”

The ‘new’ body commenced last week and was described by State sponsored news-site xinhuanet ​ as “a more powerful watchdog,”​ with ex-Director of the food safety commission, Zhang Yong, taking the reins of a reverted “ministerial-level agency to improve food and drug safety.”

The SFDA’s reputation suffered from corruption charges brought against its former chief Zheng Xiaoyu – who was executed in 2007​ – which led to the agency’s status being downgraded.

The re-elevation has mostly been to counter a number of issues the SFDA had regarding the food side of operations though the agency has also recently focused on improving drug approvals, development and distribution practices, issuing a series of reforms​ of late.

According to the South China Post​, the body had become entangled in red tape “with up to 13 government agencies controlling food and drug regulation and supervision”​ and the restructuring programme will address this, though for now the CFDA will retain the same responsibilities over drug and medical device supervision as the SFDA.

Clamp-Downs & Scandals

Though SFDA corruption has been relatively mute since 2007, the agency has been forced to issue a number of crackdowns and reforms​ in response to a number of scandals.

In 2008, unscrupulous Chinese suppliers allowed contaminated heparin – an anticoagulant - to enter the US market and was, according to the FDA speaking in the New York Times​, responsible for up to 81 deaths.

And just last year the SFDA were forced to clamp down on manufacturers​ after excessive levels of toxins tainted gel capsules, whilst Joincare Pharmaceutical Group​ was found to be manufacturing antibiotics with reprocessed cooking oil.

However, for now the CFDA will be likely to continue the SFDA’s work on stopping counterfeit drugs and illegal drugmakers. In January the SFDA upped rewards​ for people reporting illegal producers and created a special taskforce​ to target internet sellers of ersatz drugs and ingredients. 

Related topics: Markets & Regulations, Regulations

Related news

Show more

Related products

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Follow us


View more